Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 236 participants.
Also called NCT04486430
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 236 participants
- Sponsor
- Beijing Tiantan Hospital
- Daqing Oil Field Hospital
- First Affiliated Hospital of Jinan University
- First Affiliated Hospital of Wenzhou Medical University
- First Affiliated Hospital of Zhejiang University
- First Hospital of China Medical University
- General Hospital of Shenyang Military Region
- Guangzhou First People's Hospital
- Inner Mongolia Baogang Hospital
- Nanfang Hospital, Southern Medical University
- Peking University First Hospital
- Peking University Third Hospital
- Qilu Hospital of Shandong University
- Second Affiliated Hospital of Guangzhou Medical University
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Second Hospital of Shanxi Medical University
- Shandong Provincial Hospital
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- The First Affiliated Hospital of BaoTou Medical College
- The First Affiliated Hospital of Soochow University
- The First Hospital of Jilin University
- The Second Hospital of Hebei Medical University
- Tianjin Huanhu Hospital
- Tongji Hospital
- Xiangya Hospital of Central South University
- Xuanwu Hospital, Beijing
- Registry
-
NCT04486430
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04486430. Randomized; triple masking; primary purpose treatment. Start 2017-03-02 (actual); primary completion 2019-06-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset
- Acronym
- Salfaprodil
- Condition
- Stroke
- Condition
- Cerebral Infarction
- Intervention (Drug)
- Neu2000KWL
- Intervention (Drug)
- Neu2000KWL
- Intervention (Drug)
- Neu2000KWL
- Intervention (Drug)
- Placebos
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Zhejiang Apeloa Jiayuan Pharmaceutical Co. Ltd.
- Collaborator
- Subei People's Hospital of Jiangsu Province
- Collaborator
- The First Hospital of Jilin University
- Collaborator
- First Hospital of China Medical University
- Collaborator
- General Hospital of Shenyang Military Region
- Collaborator
- The First Affiliated Hospital of BaoTou Medical College
- Collaborator
- Xuanwu Hospital, Beijing
- Collaborator
- Peking University First Hospital
- Collaborator
- Peking University Third Hospital
- Collaborator
- Tianjin First Central Hospital
- Collaborator
- Tianjin Huanhu Hospital
- Collaborator
- Hebei Medical University Third Hospital
- Collaborator
- The Second Hospital of Hebei Medical University
- Collaborator
- Hebei General Hospital
- Collaborator
- Second Hospital of Shanxi Medical University
- Collaborator
- Shandong Provincial Hospital
- Collaborator
- Qilu Hospital of Shandong University
- Collaborator
- The First Affiliated Hospital of Soochow University
- Collaborator
- Nanjing PLA General Hospital
- Collaborator
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Collaborator
- Shanghai Minhang Central Hospital
- Collaborator
- First Affiliated Hospital of Zhejiang University
- Collaborator
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator
- First Affiliated Hospital of Wenzhou Medical University
- Collaborator
- Xiangya Hospital of Central South University
- Collaborator
- Guangzhou First People's Hospital
- Collaborator
- Second Affiliated Hospital of Guangzhou Medical University
- Collaborator
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Collaborator
- Nanfang Hospital, Southern Medical University
- Collaborator
- First Affiliated Hospital of Jinan University
- Collaborator
- Tongji Hospital
- Collaborator
- The Central Hospital of Lishui City
- Collaborator
- Shanghai Pudong New Area People's Hospital
- Collaborator
- Inner Mongolia Baogang Hospital
- Collaborator
- Daqing Oil Field Hospital
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 27
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 95 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 12 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 29 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 20 trials in this atlas.
Record details
- Record id
cardio:ct-nct04486430- Content hash
2db7c4ceaee6f11baf4ec50444551c2def204b1d17d9d992e4e04affaab86ba4